| Oral delivery of biologics for precision medicine M Durán‐Lobato, Z Niu, MJ Alonso Advanced Materials 32 (13), 1901935, 2020 | 217 | 2020 |
| Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies L Martín-Banderas, J Álvarez-Fuentes, M Durán-Lobato, J Prados, ... International journal of nanomedicine, 5793-5806, 2012 | 93 | 2012 |
| PEG-PGA enveloped octaarginine-peptide nanocomplexes: an oral peptide delivery strategy Z Niu, E Samaridou, E Jaumain, J Coëne, G Ullio, N Shrestha, J Garcia, ... Journal of controlled release 276, 125-139, 2018 | 85 | 2018 |
| Surface-Modified P(HEMA-co-MAA) Nanogel Carriers for Oral Vaccine Delivery: Design, Characterization, and In Vitro Targeting Evaluation M Durán-Lobato, B Carrillo-Conde, Y Khairandish, NA Peppas Biomacromolecules 15 (7), 2725-2734, 2014 | 79 | 2014 |
| Comparative study of chitosan-and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids M Durán-Lobato, L Martín-Banderas, LMD Gonçalves, ... Journal of Nanoparticle research 17, 1-17, 2015 | 78 | 2015 |
| Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape M Durán-Lobato, AM López-Estévez, AS Cordeiro, TG Dacoba, ... Advanced Drug Delivery Reviews 176, 113899, 2021 | 59 | 2021 |
| Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly (lactic-co-glycolic acid) nanoparticles M Durán-Lobato, I Muñoz-Rubio, M Holgado, J Álvarez-Fuentes, ... Journal of biomedical nanotechnology 10 (6), 1068-1079, 2014 | 53 | 2014 |
| Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility M Durán-Lobato, L Martín-Banderas, R Lopes, LMD Gonçalves, ... Drug development and industrial pharmacy 42 (2), 190-198, 2016 | 51 | 2016 |
| Functional PLGA NPs for oral drug delivery: recent strategies and developments L Martin-Banderas, M Duran-Lobato, I Munoz-Rubio, J Alvarez-Fuentes, ... Mini reviews in medicinal chemistry 13 (1), 58-69, 2013 | 43 | 2013 |
| Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity L Martín-Banderas, E Sáez-Fernández, MÁ Holgado, MM Durán-Lobato, ... International journal of pharmaceutics 443 (1-2), 103-109, 2013 | 42 | 2013 |
| Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms L Martín-Banderas, I Munoz-Rubio, J Álvarez-Fuentes, M Durán-Lobato, ... Colloids and Surfaces B: Biointerfaces 123, 114-122, 2014 | 38 | 2014 |
| Statistical analysis of solid lipid nanoparticles produced by high-pressure homogenization: a practical prediction approach M Durán-Lobato, A Enguix-González, M Fernández-Arévalo, ... Journal of nanoparticle research 15, 1-14, 2013 | 34 | 2013 |
| Role of nanotechnology for enzyme replacement therapy in lysosomal diseases. A focus on Gaucher’s disease L Martín-Banderas, MA Holgado, M Durán-Lobato, JJ Infante, ... Current Medicinal Chemistry 23 (9), 929-952, 2016 | 31 | 2016 |
| Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization M Durán-Lobato, J Álvarez-Fuentes, M Fernández-Arévalo, ... Scientific Reports 12 (1), 1297, 2022 | 20 | 2022 |
| Cannabinoid-based ocular therapies and formulations SM Saraiva, L Martín-Banderas, M Durán-Lobato Pharmaceutics 15 (4), 1077, 2023 | 7 | 2023 |
| Interés terapéutico de cannabinoides: Análisis bibliométrico en Pubmed, Scopus y Web of Science LM Banderas, MD Lobato, MÁ Holgado, JÁ Fuentes, MF Arévalo Revista Iberoamericana de Psicología y Salud 4 (2), 17-30, 2013 | 7 | 2013 |
| Cannabinoids as emergent therapy against COVID-19 J McGrail, L Martin-Banderas, M Durán-Lobato Cannabis and Cannabinoid Research 7 (5), 582-590, 2022 | 4 | 2022 |
| Ophthalmic wild olive (ACEBUCHE) oil nanoemulsions exert oculoprotective effects against oxidative stress induced by arterial hypertension Á Santana-Garrido, M Durán-Lobato, A Mate, L Martín-Banderas, ... International Journal of Pharmaceutics 649, 123602, 2024 | 2 | 2024 |
| Dataset of Comparative study of chitosan-and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids MM Durán Lobato, L Martín Banderas, L Gonçalves, ... | | 2025 |
| Dataset of Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility MM Durán Lobato, L Martín Banderas, R Lopes, L Gonçalves, ... | | 2025 |
